Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 13Active not recruiting 13Recruiting 4Terminated 3Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 3Thoracic 1Other hematologic neoplasm 1Other 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Advanced Breast Adenocarcinoma 1

Interventions

Paclitaxel 31Cyclophosphamide 25Trastuzumab 23Doxorubicin 17Docetaxel 15Carboplatin 15pembrolizumab 13Radiotherapy 11Letrozole 11Capecitabine 11exemestane 10Fulvestrant 10Magnetic Resonance Spectroscopy 8Lapatinib 8Biopsy 8eribulin 7abemaciclib 7Taxes 7Bevacizumab 7Anastrozole 7pertuzumab 6palbociclib 6Neoadjuvant Therapy 6Goserelin 6Drug Therapy 6Aromatase Inhibitors 6130-nm albumin-bound paclitaxel 6Therapeutics 5Saline Solution 5Radiosurgery 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Practice Guidelines as Topic × Breast × Clear all
NCT05244434 2022-06-09

Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast Cancer

City of Hope Medical Center

Phase NA Withdrawn
Breast

Advanced Breast Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡